Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 18, 2024Journal of Antimicrobial Chemotherapy

Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022

View Full Paper
Ask AI
Bookmark
Share

Authors

ZWZhaoquan WangHJHe JiangXPXianwu Pang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e5feebb6db6435875928e8https://doi.org/10.1093/jac/dkae260
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Full-Spectrum Surveillance of Pre-Treatment HIV Drug Resistance in Southeastern China2024 · 5 citations
  2. 2Geographical and temporal trends of HIV-1 subtypes and drug resistance in China: a nationwide study over two decades (2003–2024)2026 · 1 citations
  3. 3Characterization of Pretreatment Drug Resistance among people living with HIV from 2018 to 2022 in Guangzhou, China2024
  4. 4Molecular epidemiology and pretreatment drug resistance of HIV-1 among newly diagnosed individuals in Nanning City, Guangxi, China.2025 · 3 citations
  5. 5Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 20232024 · 12 citations